As of August 2022 Alnylam Pharmaceuticals has a market cap of $27.53 Billion. This makes Alnylam Pharmaceuticals the world's 650th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $27.53 B | 35.75% |
2021 | $20.28 B | 34.32% |
2020 | $15.10 B | 16.87% |
2019 | $12.92 B | 75.15% |
2018 | $7.37 B | -41.45% |
2017 | $12.59 B | 292.16% |
2016 | $3.21 B | -59.89% |
2015 | $8.01 B | 6.97% |
2014 | $7.48 B | 82.71% |
2013 | $4.09 B | 327.85% |
2012 | $0.95 B | 175.09% |
2011 | $0.34 B | -16.59% |
2010 | $0.41 B | -43.36% |
2009 | $0.73 B | -28.02% |
2008 | $1.02 B | -13.62% |
2007 | $1.18 B | 49.54% |
2006 | $0.79 B | 207.77% |
2005 | $0.25 B | 78.85% |
2004 | $0.14 B |
On Aug 11th, 2022 the market cap of Alnylam Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | $186.80 B | 578.47% | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | $108.58 B | 294.39% | ๐ซ๐ท France |
![]() Regeneron Pharmaceuticals REGN | $68.01 B | 147.01% | ๐บ๐ธ USA |
![]() Sarepta Therapeutics
SRPT | $9.56 B | -65.25% | ๐บ๐ธ USA |
![]() Regulus Therapeutics RGLS | $0.02 B | -99.91% | ๐บ๐ธ USA |
![]() OPKO Health
OPK | $1.92 B | -92.99% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $12.31 B | -55.27% | ๐ฎ๐ฑ Israel |
![]() Arrowhead Pharmaceuticals
ARWR | $4.82 B | -82.46% | ๐บ๐ธ USA |